Status:
COMPLETED
Immune-cell Membrane Trafficking
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of General Medical Sciences (NIGMS)
Conditions:
Severe Trauma
Eligibility:
All Genders
18+ years
Brief Summary
Organ failure following trauma is a leading cause of morbidity and mortality. It appears that the development of organ failure is a direct result of an altered immune response. This altered response r...
Eligibility Criteria
Inclusion
- age 18 years or older, blunt or penetrating trauma and
- one or more of the following: systolic blood pressure less than 90 mmHg at the scene or within one hour of arrival to the Emergency Department, 2) base deficit ≥ -6 within one hour of admission, 3) ISS greater than 25, or 4) more than 6 units of blood transfused in the first 12 hours.-
Exclusion
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
213 Patients enrolled
Trial Details
Trial ID
NCT00638521
Start Date
June 1 2008
End Date
June 1 2013
Last Update
December 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harborview Medical Center
Seattle, Washington, United States, 98104